Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Gerstoft

Showing results (221-230 of 306) with videos related to

Pageof 31
Sort By:
AIDS Research and Human Retroviruses|December 2, 2015
Neutralizing Antibody Response and Antibody-Dependent Cellular Cytotoxicity in HIV-1-Infected Individuals from Guinea-Bissau and DenmarkMarie Borggren, Sanne Skov Jensen, Leo Heyndrickx, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2014
Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug usersZitta Barrella Harboe, Mette Vang Larsen, Steen Ladelund, et al.
AIDS (London, England)|May 24, 2022
High incidence of subclinical peripheral artery disease in people with HIVMoises Alberto Suarez-Zdunek, Julie Høgh, Ditte Marie Kirkegaard-Klitbo, et al.
Basic & Clinical Pharmacology & Toxicology|October 4, 2007
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trialsUlrik S Justesen, Zoe Fox, Court Pedersen, et al.
AIDS (London, England)|August 3, 2023
Peripheral T-cell activation, Th17 cells, regulatory T-cells, and aortic aneurysm in people with HIVMalene Hove-Skovsgaard, Julie Høgh, Michael Huy Cuong Pham, et al.
Open Forum Infectious Diseases|June 4, 2025
Pneumocystis Pneumonia-Is it Still a Threat Among People With Human Immunodeficiency Virus (HIV)? A Danish HIV Cohort StudyAnne K Møller, Stine B Schnoor, Inge Petersen, et al.
Scandinavian Journal of Gastroenterology|June 23, 2020
Implementation of treatment recommendations for chronic hepatitis B in patients attending specialized hospital care in Denmark - a region wide studySigne Bollerup, Sofie Hallager, Ole Baek, et al.
Journal of the American Academy of Dermatology|March 29, 2018
Risk of skin cancer in patients with HIV: A Danish nationwide cohort studySilje Haukali Omland, Magnus Glinvad Ahlström, Jan Gerstoft, et al.
Ugeskrift for Laeger|March 1, 2008
[Changes in immunological status among newly-diagnosed HIV-infected in Denmark 1995-2005]Simon Høegh, Nicolai Lohse, Ann-Brit Eg Hansen, et al.
Plos Genetics|March 30, 2012
APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenonAndrew E Armitage, Koen Deforche, Chih-Hao Chang, et al.
Pageof 31

Showing results (221-230 of 306) with videos related to

Sort By:
Pageof 31
AIDS Research and Human Retroviruses|December 2, 2015
Neutralizing Antibody Response and Antibody-Dependent Cellular Cytotoxicity in HIV-1-Infected Individuals from Guinea-Bissau and DenmarkMarie Borggren, Sanne Skov Jensen, Leo Heyndrickx, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2014
Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug usersZitta Barrella Harboe, Mette Vang Larsen, Steen Ladelund, et al.
AIDS (London, England)|May 24, 2022
High incidence of subclinical peripheral artery disease in people with HIVMoises Alberto Suarez-Zdunek, Julie Høgh, Ditte Marie Kirkegaard-Klitbo, et al.
Basic & Clinical Pharmacology & Toxicology|October 4, 2007
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trialsUlrik S Justesen, Zoe Fox, Court Pedersen, et al.
AIDS (London, England)|August 3, 2023
Peripheral T-cell activation, Th17 cells, regulatory T-cells, and aortic aneurysm in people with HIVMalene Hove-Skovsgaard, Julie Høgh, Michael Huy Cuong Pham, et al.
Open Forum Infectious Diseases|June 4, 2025
Pneumocystis Pneumonia-Is it Still a Threat Among People With Human Immunodeficiency Virus (HIV)? A Danish HIV Cohort StudyAnne K Møller, Stine B Schnoor, Inge Petersen, et al.
Scandinavian Journal of Gastroenterology|June 23, 2020
Implementation of treatment recommendations for chronic hepatitis B in patients attending specialized hospital care in Denmark - a region wide studySigne Bollerup, Sofie Hallager, Ole Baek, et al.
Journal of the American Academy of Dermatology|March 29, 2018
Risk of skin cancer in patients with HIV: A Danish nationwide cohort studySilje Haukali Omland, Magnus Glinvad Ahlström, Jan Gerstoft, et al.
Ugeskrift for Laeger|March 1, 2008
[Changes in immunological status among newly-diagnosed HIV-infected in Denmark 1995-2005]Simon Høegh, Nicolai Lohse, Ann-Brit Eg Hansen, et al.
Plos Genetics|March 30, 2012
APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenonAndrew E Armitage, Koen Deforche, Chih-Hao Chang, et al.
Pageof 31